AzTrials
AzTrials

Inguinal HerniaNCT02030223

Transversus Abdominis Plane Block and Inguinal Hernia Repair

A study testing Transversus abdominis plane block in people with Inguinal Hernia and Abdominal Wall Muscles, run by Papacharalampous Panagiota at 1 site in Greece.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This prospective, randomized, double blinded, placebo-controlled study is designed to evaluate the postoperative analgesic efficacy of the ultrasound-guided transversus abdominis plane block with ropivacaine 0,75 %, in patients undergoing unilateral inguinal hernia repair with a mesh under general anaesthesia, and how… Read more about this study

Who is it for?
Ages 18 to 80 years
What is being tested?
Transversus abdominis plane block
Type of treatment
Surgery or procedure
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
59 participants
Where
1 siteGreece
Study dates
Jan 2014to Dec 2017
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 80 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • ASA I-III patients undergoing inguinal hernia repair with a mesh
  • age between 18 and 75 years old
  • ability to read and write greek
  • -

Who cannot join

  • Inability to consent to the study
  • BMI >40kg/m2
  • Skin infection at the puncture site
  • Contraindication to mono-amide local anaesthetics, paracetamol, NSAID's (parecoxib)
  • Preoperative use of opioids or NSAID's for chronic pain conditions

Trial locations and contacts

1 site in 1 country.

Greece1 site
  • Aretaieion University Hospital

    Athens

Other trials in Greece

About this study

Official title: The Analgesic Efficacy of the Ultrasound Guided Transversus Abdominis Plane Block After Inguinal Hernia Repair With a Mesh.

This prospective, randomized, double blinded, placebo-controlled study is designed to evaluate the postoperative analgesic efficacy of the ultrasound-guided transversus abdominis plane block with ropivacaine 0,75 %, in patients undergoing unilateral inguinal hernia repair with a mesh under general anaesthesia, and how the efficiency of early postoperative analgesia achieved correlates with the risk of developing a chronic pain state, a not uncommon condition after this type of surgery.

Being tested
Transversus abdominis plane block
Keywords
transversus abdominis plane block, inguinal hernia repair, acute postoperative pain, neuropathic pain
Medical subject headings
Hernia, Inguinal, Pain, Postoperative, Neuralgia

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Transversus abdominis plane blockProcedure or surgery

    ultrasound guided transversus abdominis plane block

Study groups in NCT02030223
Study groupRoleWhat they receive
Transversus abdominis plane block with 20 ml ropivacaine 0,75%Active comparatorTransversus abdominis plane block with 20 ml ropivacaine 0,75%
Receives: Procedure: Transversus abdominis plane block
Transversus abdominis plane block with 20 ml salinePlacebo comparatorTransversus abdominis plane block with 20 ml saline
Receives: Procedure: Transversus abdominis plane block

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Pain scores at rest and with movement using the numerical rating scale (NRS)

    Measured: 3, 6 and 24 hours postoperatively

Secondary outcomes (1)
  1. Incidence of chronic pain

    Measured: 6 months after surgery

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted8 Jan 2014 (estimated)
  2. Study startJan 2014
  3. Primary completionDec 2017
  4. Study completionDec 2017

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Quadruple blind
Who is masked
Participant, Care provider, Investigator, Outcomes assessor
Enrolment
59 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02030223
Sponsor's protocol ID
PAM-2345-1786
Status last verified
Feb 2018
First submitted
7 Jan 2014
Last updated
19 Feb 2018
Results posted
No
Data monitoring committee
Yes

Publications

  • Milone M, Di Minno MN, Musella M, Maietta P, Salvatore G, Iacovazzo C, Milone F. Outpatient inguinal hernia repair under local anaesthesia: feasibility and efficacy of ultrasound-guided transversus abdominis plane block. Hernia. 2013 Dec;17(6):749-55. doi: 10.1007/s10029-012-1022-2. Epub 2012 Nov 16.

    PubMed 23160979
  • Petersen PL, Mathiesen O, Stjernholm P, Kristiansen VB, Torup H, Hansen EG, Mitchell AU, Moeller A, Rosenberg J, Dahl JB. The effect of transversus abdominis plane block or local anaesthetic infiltration in inguinal hernia repair: a randomised clinical trial. Eur J Anaesthesiol. 2013 Jul;30(7):415-21. doi: 10.1097/EJA.0b013e32835fc86f.

    PubMed 23549122

Questions about this trial

What is this clinical trial studying?

A study testing Transversus abdominis plane block in people with Inguinal Hernia and Abdominal Wall Muscles, run by Papacharalampous Panagiota at 1 site in Greece.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 19 Feb 2018. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Greece. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Pain scores at rest and with movement using the numerical rating scale (NRS) (time frame: 3, 6 and 24 hours postoperatively). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT02030223, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 19 Feb 2018.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in